ArticleHawai'i journal of health & social welfare2026
Death after Total Hip Arthroplasty in Patients with Compensated Heart Failure: Retrospective Cohort Study.
Article in Hawai'i journal of health & social welfare, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Total hip arthroplasty (THA) is the preferred treatment for femoral neck fracture when functional longevity is expected, but congestive heart failure (CHF) is a risk factor for mortality. The hypothesis of this study is that mortality risk increases with disease severity, influencing the choice between total and hemiarthroplasty. This study queried the National Surgical Quality Improvement database for patients treated for an acute, closed, intracapsular femoral neck fracture, identifying 4486 THA and 34 282 hemiarthroplasty recipients. Subjects were stratified by preoperative risk factors, New York Heart Association categories of mild, moderate, and severe CHF, and odds of death within 30 days. The 30-day postoperative mortality rates for total and hemiarthroplasty were 2.1% (n = 95) and 5.4% (n = 1857), respectively. The 30-day postoperative mortality of patients undergoing THA with mild CHF was 14.3%, and moderate CHF was 21.4%., and for patients undergoing hemiarthroplasty with mild CHF was 11.4%, moderate CHF was 13.9%, and severe CHF was 18.4%. Mild (adjusted odds ratio [AOR] 1.63, 95% Confidence Interval [CI] 1.24-2.14), moderate (AOR 2.21, CI 1.49-3.30), and severe (AOR 2.89, CI 1.41-5.93) CHF was associated with death within 30 days of hemiarthroplasty. Mild (AOR 5.37, 95% CI 2.16-13.38) and moderate (AOR 12.00, CI 3.42-42.17) CHF was associated with death within 30 days of THA. Patients with CHF had increased mortality after THA for acute femoral neck fracture, suggesting it is not a modifiable risk factor. Hemiarthroplasty is a reasonable choice with CHF given evidence of unfavorable survival.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.